FAKTOR-OPTIONSSCHEIN - ROCHE GS Share Price

Certificat

DE000SF3KGU0

Delayed Deutsche Boerse AG 14:43:31 30/05/2024 BST
2.41 EUR +14.76% Intraday chart for FAKTOR-OPTIONSSCHEIN - ROCHE GS
Current month-43.55%
1 month-41.99%
Date Price Change
30/05/24 2.41 +14.76%
29/05/24 2.1 -4.98%
28/05/24 2.21 +6.25%
27/05/24 2.08 +4.52%
24/05/24 1.99 -1.00%

Delayed Quote Deutsche Boerse AG

Last update May 30, 2024 at 02:43 pm

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying ROCHE HOLDING AG
IssuerLogo Issuer Société Générale Société Générale
WKN SF3KGU
ISINDE000SF3KGU0
Date issued 13/08/2021
Strike 366.6 CHF
Maturity Unlimited
Parity 1 : 1
Emission price 10.41
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 20.68
Lowest since issue 0.93
Spread 0.04
Spread %1.62%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
229.6 CHF
Average target price
277.5 CHF
Spread / Average Target
+20.87%
Consensus